Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Lixte Biotechnology Holdings (LIXT) Return on Assets (2016)

Lixte Biotechnology Holdings' Return on Assets history spans 6 years, with the latest figure at 1.4% for Q3 2016.

  • For Q3 2016, Return on Assets rose 59.0% year-over-year to 1.4%; the TTM value through Sep 2016 reached 1.4%, up 59.0%, while the annual FY2015 figure was 4.58%, N/A changed from the prior year.
  • Return on Assets reached 1.4% in Q3 2016 per LIXT's latest filing, down from 1.35% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 1.35% in Q2 2016 to a low of 33.8% in Q1 2014.
  • Average Return on Assets over 5 years is 9.19%, with a median of 6.66% recorded in 2012.
  • Peak YoY movement for Return on Assets: tumbled -2675bps in 2014, then surged 3194bps in 2015.
  • A 5-year view of Return on Assets shows it stood at 6.28% in 2012, then crashed by -172bps to 17.07% in 2013, then surged by 34bps to 11.26% in 2014, then soared by 78bps to 2.5% in 2015, then soared by 44bps to 1.4% in 2016.
  • Per Business Quant, the three most recent readings for LIXT's Return on Assets are 1.4% (Q3 2016), 1.35% (Q2 2016), and 1.86% (Q1 2016).